ShortageWatch

Mylan Pharmaceuticals Inc., a Viatris Company

7 active drug shortages reported by Mylan Pharmaceuticals Inc., a Viatris Company.

Lisdexamfetamine Dimesylate Capsule

Currently in Shortage
Category
Psychiatry
Reason
Not specified
Updated
04/03/2026

Lisdexamfetamine Dimesylate Capsule

Currently in Shortage
Category
Psychiatry
Reason
Not specified
Updated
04/03/2026

Lisdexamfetamine Dimesylate Capsule

Currently in Shortage
Category
Psychiatry
Reason
Not specified
Updated
04/03/2026

Lisdexamfetamine Dimesylate Capsule

Currently in Shortage
Category
Psychiatry
Reason
Not specified
Updated
04/03/2026

Lisdexamfetamine Dimesylate Capsule

Currently in Shortage
Category
Psychiatry
Reason
Not specified
Updated
04/03/2026

Lisdexamfetamine Dimesylate Capsule

Currently in Shortage
Category
Psychiatry
Reason
Not specified
Updated
04/03/2026

Lisdexamfetamine Dimesylate Capsule

Currently in Shortage
Category
Psychiatry
Reason
Not specified
Updated
04/03/2026

This information is not medical advice. Consult your pharmacist. Data is sourced from the FDA Drug Shortage Database and may not reflect real-time inventory at your facility. ShortageWatch is independent and not affiliated with the FDA.